Anti-oestrogen action in experimental breast cancer.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004305:Dose-Response Relationship, Drug; D004717:Endometrium / Q000166:cytology / Q000473:pathology; D004965:Estrogen Antagonists / Q000378:metabolism / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006984:Hypertrophy; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D008938:Mitosis / Q000187:drug effects; D011388:Prolactin / Q000037:antagonists & inhibitors; D051381:Rats; D011960:Receptors, Estrogen / Q000187:drug effects; D013629:Tamoxifen / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014599:Uterus / Q000187:drug effects
D004965:Estrogen Antagonists; D004967:Estrogens; D011960:Receptors, Estrogen; D013629:Tamoxifen; D015127:9,10-Dimethyl-1,2-benzanthracene; D011388:Prolactin